2021-2032 All Rights Reserved. Online Journal of Veterinary Research. You may not store these pages in any form except for your own personal use. All other usage or distribution is illegal under International copyright treaties. Permission to use any of these pages in any other way besides the before mentioned must be gained in writing from the publisher. This article is exclusively copyrighted in its entirety to OJVR publications. This article may be copied once but may not be, reproduced or re-transmitted without the express permission of the editor.


OJVRTM

Online Journal of Veterinary Research

(Including Medical and Laboratory Research)

Established 1994

ISSN 1328-925X

Volume 26 (2):137-147, 2022.


Herd immunity in buffaloes by intranasal live gdhA P. multocida B:2 vaccine

 

Rafidah O1,2, Zamri-Saad M1, Nasip E2, Saharee AA1

 

1Faculty of Veterinary Medicine, Universiti Putra Malaysia, and 2Department of Veterinary Services and Animal Industry, Kota Kinabalu, Sabah, Malaysia.

 

Abstract

 

Rafidah O, Zamri-Saad M, Nasip E, Saharee AA., Herd immunity in buffaloes by intranasal live gdhA P. multocida B:2 vaccine, Onl J Vet Res., 26 (2):137-147, 2022. We report herd immunity to haemorrhagic septicaemia (HS) in large herds of buffalo given intranasal live attenuated gdhA P. multocida B:2. Three groups of 30 - 50 buffaloes from endemic location with HS outbreak reported 2 months earlier and from non-endemic locations were grazed without vaccination. Then 30% in each group were inoculated 5ml 106 CFU/mL live attenuated gdhA P. multocida B:2 intranasally. After vaccination, buffaloes commingled with other animals and a booster was given 10 months after. Serum was taken from 30% buffaloes of each group prior to and every 2 month for 22 months to determine herd immune status by ELISA. The endemic or non-endemic herd status was compared 15 non-vaccinated controls. We found (p<0.05) higher herd antibody levels in both endemic and non-endemic areas before vaccination. However, afte, antibodies in both areas gradually increase and peaking (p<0.05) at 6 months then gradually falling to 10 months. Following booster dose at month 10, the herd antibody levels decreased drastically to an insignificant (p>0.05) level as the unvaccinated group at 12-14 months before significantly (p<0.05) recovered thereafter until the end of 22-month study period. It was concluded that field vaccination using gdhA derivative P. multocida B:2 increased the herd immunity that lasted between 8 and 10 months before a booster dose was required.

 

Key words: gdhA derivative Pasteurella multocida B:2; immune response; field buffalo.


MAIN

 

FULL-TEXT (SUBSCRIBE OR PURCHASE TITLE)